Bottom line
Is FSMEX a good fund? The bottom line
FSMEX is an actively managed technology sector mutual fund from Fidelity.
Annual fees run 0.62% — about $62 a year on every $10,000 invested, cheaper than 67% of technology sector funds we track.
It returned +4.8% over one year, +1.6% a year over five years, +11.3% a year over ten (as of Apr 30, 2026, per its prospectus).
With $3.0 billion in net assets and 66 holdings, its largest position is Danaher Corp (15.1%) and the top 10 make up 63.5% of the portfolio.
What to watch
- 5-year return in the bottom quarter of its category
- Concentrated: top 10 holdings are 63.5% of assets
Updated Nov 19, 2026
What FSMEX invests in
Medical Technology and Devices Portfolio seeks capital appreciation.
Normally investing at least 80% of assets in securities of companies principally engaged in research, development, manufacture, distribution, supply, or sale of medical equipment and devices and related technologies, companies enabling drug discovery, and companies providing information technology services primarily to health care providers. These companies may include, for example, manufacturers of health care equipment and supplies including drug delivery systems and eye care products, firms providing services directly related to the pharmaceutical and biotechnology industries, and companies providing applications, systems and/or data processing software, and IT consulting services and tools to doctors, hospitals, and health care businesses. For purposes of the fund's policy to normally invest at least 80% of its assets in securities of companies principally engaged in the business…
From the fund's prospectus (filed Apr 24, 2026).
FSMEX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| FSMEX | +4.8% | +1.6% | +11.3% |
| Technology Sector median | +24.0% | +10.0% | +16.7% |
Source: Fund prospectus, as of Apr 30, 2026
What FSMEX costs
On a $10,000 investment, FSMEX's 0.62% expense ratio costs about $62 a year. The prospectus estimates $774 in total costs over 10 years (assuming 5% annual returns). The median technology sector fund charges 0.75%.
FSMEX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Danaher Corp | 15.09% |
| 2 | Thermo Fisher Scientific Inc | 14.06% |
| 3 | Intuitive Surgical Inc | 7.45% |
| 4 | Boston Scientific Corp | 5.11% |
| 5 | Edwards Lifesciences Corp | 4.21% |
| 6 | Stryker Corp | 4.18% |
| 7 | Abbott Laboratories | 3.85% |
| 8 | Waters Corp | 3.27% |
| 9 | Agilent Technologies Inc | 3.21% |
| 10 | West Pharmaceutical Svcs Inc | 3.09% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 63.5% of the fund. See all top 25 holdings and asset mix →